All News

In an attempt to develop a multivariable predictive model for days with new-onset migraine headaches, researchers found episodic migraine attacks were not predictable based on self-prediction or on self-reported exposure to common trigger factors.

Research on the long-term use of ozanimod in relapsing forms of multiple sclerosis (MS) has shown the treatment is effective with no new safety concerns.

Migraine prevention helps drive down functional disability among migraineurs, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.

Two women are awarded the Nobel Prize in Chemistry for CRISPR; Eli Lilly partners with DexCom, Inc; the US arm of AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine trial remains halted.

More Humana doctors are taking on full global risk under Medicare Advantage than are still using traditional fee-for-service.

Because patients with chronic migraine experience more monthly migraine days (MMD) than those with episodic migraine, chronic migraineurs will experience a greater reduction of MMD with erenumab, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

At a session Tuesday at the Migraine Trust International Symposium, one presentation delved into findings published this year in medication overuse headaches, prevention, and pathophysiology of migraine as well as cluster headaches.

In this episode of Managed Care Cast, we speak with a male patient with breast cancer who was diagnosed with metastatic disease in 2016 about how he lives his life and what he wants people to know about this rare cancer.

In this study from Cape Town, South Africa, patients with comorbid HIV and a history of mental illness had an increased risk of mortality from all causes.

Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted over the past 15 years, independent of socioeconomic status.

Treatment guidelines for comorbid depression and migraine are warranted to ensure optimal efficacy and avoid possible pitfalls in psychopharmacotherapy, according to study results.

Medication overuse headache is a peculiar disorder where the cure becomes the cause, said Rigmor Jensen, MD, professor of neurology at The University of Copenhagen and director of the Danish Headache Center.

The CDC confirms that SARS-CoV-2 can be spread via airborne particles; the White House blocks new FDA guidelines on bringing potential vaccines to market; the Supreme Court will hear a case on pharmacy benefit managers.

Telehealth claims peaked in June 2020, then eased off a bit in July. There were more telehealth claims in the Northeast than in other regions.

Oxymetazoline, 0.1% may hold potential as a promising treatment option for individuals with acquired blepharoptosis, according to results of a pooled analysis published in JAMA Ophthalmology.

Personalized recommendations for patients with non–small cell lung cancer with squamous histology could benefit from research on treatment choice and biomarkers, noted Blythe Adamson, PhD, MPH, principal quantitative scientist at Flatiron Health.

Compared with 2018 and 2019, data from 2020 show reports of headache frequency increased, despite decreases in reports of the 4 most common migraine triggers, said Faraidoon Haghdoost, MD, a general practitioner and PhD student at The George Institute for Global Health in Sydney, Australia.

Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.

About 3 days after being airlifted to the hospital to be treated for symptoms stemming from coronavirus disease 2019 (COVID-19) infection, the president is returning to the White House.

Targeted tumor delivery of irinotecan through sacituzumab govitecan can help to reduce treatment-related toxicities, noted Timothy A. Yap, MBBS, PhD, FRCP, medical director of the Institute for Applied Cancer Science, MD Anderson Cancer Center.

Telemedicine was indicated to provide complete and appropriate care for addressing pediatric sleep disorders such as insomnia and circadian rhythm disorders, whereas obstructive sleep apnea was better evaluated in office.

Abstracts presented at this year’s Migraine Trust International Symposium (MTIS) show how researchers analyzed the efficacy, tolerability, and safety profile of Reyvow (lasmiditan), a prescription drug used to treat migraine attacks.

The National Insistutes of Health (NIH) study aims to discover new forms of diabetes, understand what makes them unique, and identify root causes.

Five things to know on a vaccine for the coronavirus disease 2019 (COVID-19) were spotlighted; Bristol Myers Squibb (BMS) will buy heart drugmaker MyoKardia Inc for $13.1 billion; a look at the importance of health information technology (IT) in rural areas.

Data from the long-term study of erenumab are very surprising in the sense that many of the patients continued to have significant results which continued for the duration of the study, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

Two Americans and a British scientist share the 2020 Prize for Physiology or Medicine for work in the 1970s through the 1990s. The rise of agents to treat hepatitis C virus has created vexing questions in managed care.

During a 1-hour free webinar from MJH Life Sciences™’s COVID-19 Coalition, experts discussed various myths around the coronavirus disease 2019 (COVID-19) pandemic.

One development in migraine science is the hypothesis that sex differences in migraine prevalence may be accounted for, in part, at the nociceptor level, said Frank Porreca, PhD, professor of pharmacology and anesthesiology at the University of Arizona and a member of the Department of Collaborative Research at Mayo Clinic in Arizona.